KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹235 Cr | ₹198 Cr | ₹154 Cr | ₹140 Cr | ₹114 Cr |
What is the latest Revenue of KILITCH DRUGS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹235 Cr |
| Mar2025 | ₹198 Cr |
| Mar2024 | ₹154 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹114 Cr |
How is Revenue of KILITCH DRUGS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹235 Cr | 18.74 | |
| Mar2025 | ₹198 Cr | 28.47 | |
| Mar2024 | ₹154 Cr | 10.58 | |
| Mar2023 | ₹140 Cr | 22.20 | |
| Mar2022 | ₹114 Cr | - | |
Compare Revenue of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹722.1 Cr | -0.9% | -3.9% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -0.9% |
-3.9% |
8.7% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses